Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

Unlocking New Hope: How Elacestrant Revolutionizes Breast Cancer Treatment

Discover how elacestrant, the first oral SERD approved for ER-positive, HER2-negative breast cancer with ESR1 mutations, is transforming treatment paradigms.

Aurora Long
Aug 10, 2025

Popular Articles